<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33673590</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>16</Day></DateCompleted><DateRevised><Year>2021</Year><Month>08</Month><Day>16</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>3</Issue><PubDate><Year>2021</Year><Month>Feb</Month><Day>27</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>Circulation and Molecular Epidemiology of Enteroviruses in Paralyzed, Immunodeficient and Healthy Individuals in Tunisia, a Country with a Polio-Free Status for Decades.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">380</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/v13030380</ELocationID><Abstract><AbstractText>This report is an overview of enterovirus (EV) detection in Tunisian polio-suspected paralytic cases (acute flaccid paralysis (AFP) cases), healthy contacts and patients with primary immunodeficiencies (PID) during an 11-year period. A total of 2735 clinical samples were analyzed for EV isolation and type identification, according to the recommended protocols of the World Health Organization. Three poliovirus (PV) serotypes and 28 different nonpolio enteroviruses (NPEVs) were detected. The NPEV detection rate was 4.3%, 2.8% and 12.4% in AFP cases, healthy contacts and PID patients, respectively. The predominant species was EV-B, and the circulation of viruses from species EV-A was noted since 2011. All PVs detected were of Sabin origin. The PV detection rate was higher in PID patients compared to AFP cases and contacts (6.8%, 1.5% and 1.3% respectively). PV2 was not detected since 2015. Using nucleotide sequencing of the entire VP1 region, 61 strains were characterized as Sabin-like. Among them, six strains of types 1 and 3 PV were identified as pre-vaccine-derived polioviruses (VDPVs). Five type 2 PV, four strains belonging to type 1 PV and two strains belonging to type 3 PV, were classified as iVDPVs. The data presented provide a comprehensive picture of EVs circulating in Tunisia over an 11-year period, reveal changes in their epidemiology as compared to previous studies and highlight the need to set up a warning system to avoid unnoticed PVs.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chouikha</LastName><ForeName>Anissa</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-5616-0204</Identifier><AffiliationInfo><Affiliation>Laboratory of Clinical Virology, WHO Reference Laboratory for Poliomyelitis and Measles in the Eastern Mediterranean Region, Pasteur Institute of Tunis, University Tunis El Manar (UTM), Tunis 1068, Tunisia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Laboratory, LR20IPT02, Pasteur Institute of Tunis, Tunis 1006, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rezig</LastName><ForeName>Dorra</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Laboratory of Clinical Virology, WHO Reference Laboratory for Poliomyelitis and Measles in the Eastern Mediterranean Region, Pasteur Institute of Tunis, University Tunis El Manar (UTM), Tunis 1068, Tunisia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Laboratory, LR20IPT02, Pasteur Institute of Tunis, Tunis 1006, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Driss</LastName><ForeName>Nadia</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Laboratory of Clinical Virology, WHO Reference Laboratory for Poliomyelitis and Measles in the Eastern Mediterranean Region, Pasteur Institute of Tunis, University Tunis El Manar (UTM), Tunis 1068, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abdelkhalek</LastName><ForeName>Ichrak</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Laboratory of Clinical Virology, WHO Reference Laboratory for Poliomyelitis and Measles in the Eastern Mediterranean Region, Pasteur Institute of Tunis, University Tunis El Manar (UTM), Tunis 1068, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ben Yahia</LastName><ForeName>Ahlem</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Laboratory of Clinical Virology, WHO Reference Laboratory for Poliomyelitis and Measles in the Eastern Mediterranean Region, Pasteur Institute of Tunis, University Tunis El Manar (UTM), Tunis 1068, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Touzi</LastName><ForeName>Henda</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Laboratory of Clinical Virology, WHO Reference Laboratory for Poliomyelitis and Measles in the Eastern Mediterranean Region, Pasteur Institute of Tunis, University Tunis El Manar (UTM), Tunis 1068, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meddeb</LastName><ForeName>Zina</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Laboratory of Clinical Virology, WHO Reference Laboratory for Poliomyelitis and Measles in the Eastern Mediterranean Region, Pasteur Institute of Tunis, University Tunis El Manar (UTM), Tunis 1068, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ben Farhat</LastName><ForeName>Essia</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>National Program of Immunization Basic Health Care Division, Ministry of Health Tunis, Tunis 1006, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yahyaoui</LastName><ForeName>Mahrez</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>National Program of Immunization Basic Health Care Division, Ministry of Health Tunis, Tunis 1006, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Triki</LastName><ForeName>Henda</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Laboratory of Clinical Virology, WHO Reference Laboratory for Poliomyelitis and Measles in the Eastern Mediterranean Region, Pasteur Institute of Tunis, University Tunis El Manar (UTM), Tunis 1068, Tunisia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Laboratory, LR20IPT02, Pasteur Institute of Tunis, Tunis 1006, Tunisia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>02</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011055">Poliovirus Vaccine, Oral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="N">Enterovirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017720" MajorTopicYN="N">Molecular Epidemiology</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010243" MajorTopicYN="N">Paralysis</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010802" MajorTopicYN="N">Phylogeny</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011051" MajorTopicYN="N">Poliomyelitis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017955" MajorTopicYN="N">Poliovirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011055" MajorTopicYN="N">Poliovirus Vaccine, Oral</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014416" MajorTopicYN="N" Type="Geographic">Tunisia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Picornaviridae</Keyword><Keyword MajorTopicYN="N">VDPV</Keyword><Keyword MajorTopicYN="N">acute flaccid paralysis</Keyword><Keyword MajorTopicYN="N">epidemiology</Keyword><Keyword MajorTopicYN="N">nonpolio enterovirus</Keyword><Keyword MajorTopicYN="N">poliovirus</Keyword><Keyword MajorTopicYN="N">primary immunodeficiencies</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>2</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>2</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>2</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>3</Month><Day>6</Day><Hour>1</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>2</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33673590</ArticleId><ArticleId IdType="pmc">PMC7997211</ArticleId><ArticleId IdType="doi">10.3390/v13030380</ArticleId><ArticleId IdType="pii">v13030380</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Jubelt B., Lipton H.L. Enterovirus/Picornavirus infections. Handb. Clin. Neurol. 2014;123:379&#x2013;416. doi: 10.1016/B978-0-444-53488-0.00018-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-444-53488-0.00018-3</ArticleId><ArticleId IdType="pubmed">25015496</ArticleId></ArticleIdList></Reference><Reference><Citation>Zell R., Delwart E., Gorbalenya A.E., Hovi T., King A.M.Q., Knowles N.J., Lindberg A.M., Pallansch M.A., Palmenberg A.C., Reuter G., et al. ICTV Virus Taxonomy Profile: Picornaviridae. J. Gen. Virol. 2017;98:2421&#x2013;2422. doi: 10.1099/jgv.0.000911.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jgv.0.000911</ArticleId><ArticleId IdType="pmc">PMC5725991</ArticleId><ArticleId IdType="pubmed">28884666</ArticleId></ArticleIdList></Reference><Reference><Citation>Tapparel C., Siegrist F., Petty T.J., Kaiser L. Picornavirus and enterovirus diversity with associated human diseases. Infect. Genet. Evol. 2013;14:282&#x2013;293. doi: 10.1016/j.meegid.2012.10.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.meegid.2012.10.016</ArticleId><ArticleId IdType="pubmed">23201849</ArticleId></ArticleIdList></Reference><Reference><Citation>Morales M., Tangermann R.H., Wassilak S.G. Progress toward Polio Eradication&#x2014;Worldwide, 2015&#x2013;2016. MMWR. Morb. Mortal. Wkly. Rep. 2016;65:470&#x2013;473. doi: 10.15585/mmwr.mm6518a4.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6518a4</ArticleId><ArticleId IdType="pubmed">27171208</ArticleId></ArticleIdList></Reference><Reference><Citation>Previsani N., Singh H., Pierre J.S., Boualam L., Fournier-Caruana J., Sutter R.W., Zaffran M. Progress Toward Containment of Poliovirus Type 2&#x2014;Worldwide, 2017. Morb. Mortal. Wkly. Rep. 2017;66:649&#x2013;652. doi: 10.15585/mmwr.mm6624a5.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6624a5</ArticleId><ArticleId IdType="pmc">PMC5657795</ArticleId><ArticleId IdType="pubmed">28640795</ArticleId></ArticleIdList></Reference><Reference><Citation>Two out of Three Wild Poliovirus Strains Eradicated.  [(accessed on 16 February 2021)]; Available online:  https://polioeradication.org/news-post/two-out-of-three-wild-poliovirus-strains-eradicated/</Citation></Reference><Reference><Citation>Centers for Disease Control and Prevention (CDC) Laboratory surveillance for wild and vaccine-derived polioviruses, January 2004&#x2013;June 2005. MMWR Morb Mortal Wkly Rep. 2005;54:958&#x2013;961.</Citation><ArticleIdList><ArticleId IdType="pubmed">16195695</ArticleId></ArticleIdList></Reference><Reference><Citation>Kew O.M., Sutter R.W., De Gourville E.M., Dowdle W.R., Pallansch M.A. Vaccine-derived polioviruses and the endgame strategy for global polio eradication. Annu. Rev. Microbiol. 2005;59:587&#x2013;635. doi: 10.1146/annurev.micro.58.030603.123625.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.micro.58.030603.123625</ArticleId><ArticleId IdType="pubmed">16153180</ArticleId></ArticleIdList></Reference><Reference><Citation>Dunn G., Klapsa D., Wilton T., Stone L., Minor P.D., Martin J. Twenty-Eight Years of Poliovirus Replication in an Immunodeficient Individual: Impact on the Global Polio Eradication Initiative. PLoS Pathog. 2015;11:e1005114. doi: 10.1371/journal.ppat.1005114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1005114</ArticleId><ArticleId IdType="pmc">PMC4552295</ArticleId><ArticleId IdType="pubmed">26313548</ArticleId></ArticleIdList></Reference><Reference><Citation>Hertel N.T., Pedersen F.K., Heilmann C. Coxsackie B3 virus encephalitis in a patient with agammaglobulinaemia. Eur. J. Nucl. Med. Mol. Imaging. 1989;148:642&#x2013;643. doi: 10.1007/BF00441520.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00441520</ArticleId><ArticleId IdType="pubmed">2545452</ArticleId></ArticleIdList></Reference><Reference><Citation>McKinney J.R.E., Katz S.L., Wilfert C.M. Chronic Enteroviral Meningoencephalitis in Agammaglobulinemic Patients. Clin. Infect. Dis. 1987;9:334&#x2013;356. doi: 10.1093/clinids/9.2.334.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/clinids/9.2.334</ArticleId><ArticleId IdType="pubmed">3296100</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng F.W.T., Chan P.K.S., Ho W.C.S., Wong F.Y.W., Leung T.F. Recurrent enterovirus encephalitis: Chance or something else? BMJ Case Rep. 2009;2009 doi: 10.1136/bcr.12.2008.1358.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr.12.2008.1358</ArticleId><ArticleId IdType="pmc">PMC3028059</ArticleId><ArticleId IdType="pubmed">21686352</ArticleId></ArticleIdList></Reference><Reference><Citation>Majumdar M., Sharif S., Klapsa D., Wilton T., Alam M.M., Fernandez-Garcia M.D., Rehman L., Mujtaba G., McAllister G., Harvala H., et al. Environmental Surveillance Reveals Complex Enterovirus Circulation Patterns in Human Populations. Open Forum Infect. Dis. 2018;5:ofy250. doi: 10.1093/ofid/ofy250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofy250</ArticleId><ArticleId IdType="pmc">PMC6201154</ArticleId><ArticleId IdType="pubmed">30377626</ArticleId></ArticleIdList></Reference><Reference><Citation>Pons-Salort M., Oberste M.S., Pallansch M.A., Abedi G.R., Takahashi S., Grenfell B.T., Grassly N.C. The seasonality of nonpolio enteroviruses in the United States: Patterns and drivers. Proc. Natl. Acad. Sci. USA. 2018;115:3078&#x2013;3083. doi: 10.1073/pnas.1721159115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1721159115</ArticleId><ArticleId IdType="pmc">PMC5866597</ArticleId><ArticleId IdType="pubmed">29507246</ArticleId></ArticleIdList></Reference><Reference><Citation>Bahri O., Rezig D., Ben Nejma-Oueslati B., Ben Yahia A., Ben Sassi J., Hogga N., Sadraoui A., Triki H. Enteroviruses in Tunisia: Virological surveillance over 12 years (1992&#x2013;2003) J. Med. Microbiol. 2005;54:63&#x2013;69. doi: 10.1099/jmm.0.45695-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jmm.0.45695-0</ArticleId><ArticleId IdType="pubmed">15591257</ArticleId></ArticleIdList></Reference><Reference><Citation>Haddad-Boubaker S., Ben Yahia A., Bahri O., Morel V., Balanant J., Delpeyroux F., Triki H. Genetic features of polioviruses isolated in Tunisia, 1991&#x2013;2006. J. Clin. Virol. 2008;41:81&#x2013;86. doi: 10.1016/j.jcv.2007.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2007.10.002</ArticleId><ArticleId IdType="pubmed">18023246</ArticleId></ArticleIdList></Reference><Reference><Citation>Harvala H., Broberg E., Benschop K., Berginc N., Ladhani S.N., Susi P., Christiansen C., McKenna J., Allen D., Makiello P., et al. Recommendations for enterovirus diagnostics and characterisation within and beyond Europe. J. Clin. Virol. 2018;101:11&#x2013;17. doi: 10.1016/j.jcv.2018.01.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2018.01.008</ArticleId><ArticleId IdType="pubmed">29414181</ArticleId></ArticleIdList></Reference><Reference><Citation>Rezig D., Ben Yahia A., Ben Abdallah H., Bahri O., Triki H. Molecular characterization of coxsackievirus B5 isolates. J. Med Virol. 2003;72:268&#x2013;274. doi: 10.1002/jmv.10579.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.10579</ArticleId><ArticleId IdType="pubmed">14695669</ArticleId></ArticleIdList></Reference><Reference><Citation>Oberste M.S., Maher K., Flemister M.R. Comparison of classic and molecular approaches for the identification of untypeableenteroviruses. J. Clin. Microbiol. 2000;38:1170&#x2013;1174. doi: 10.1128/JCM.38.3.1170-1174.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.38.3.1170-1174.2000</ArticleId><ArticleId IdType="pmc">PMC86366</ArticleId><ArticleId IdType="pubmed">10699015</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar S., Stecher G., Tamura K. MEGA7: Molecular Evolutionary Genetics Analysis Version 7.0 for Bigger Datasets. Mol. Biol. Evol. 2016;33:1870&#x2013;1874. doi: 10.1093/molbev/msw054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/molbev/msw054</ArticleId><ArticleId IdType="pmc">PMC8210823</ArticleId><ArticleId IdType="pubmed">27004904</ArticleId></ArticleIdList></Reference><Reference><Citation>Oberste M.S., Maher K., Kilpatrick D.R., Flemister M.R., Brown B.A., Pallansch M.A. Typing of human enteroviruses by partial sequencing of VP1. J. Clin. Microbiol. 1999;37:1288&#x2013;1293. doi: 10.1128/JCM.37.5.1288-1293.1999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.37.5.1288-1293.1999</ArticleId><ArticleId IdType="pmc">PMC84754</ArticleId><ArticleId IdType="pubmed">10203472</ArticleId></ArticleIdList></Reference><Reference><Citation>Oberste M.S., Maher K., Kilpatrick D.R., Pallansch M.A. Molecular Evolution of the Human Enteroviruses: Correlation of Serotype with VP1 Sequence and Application to Picornavirus Classification. J. Virol. 1999;73:1941&#x2013;1948. doi: 10.1128/JVI.73.3.1941-1948.1999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.73.3.1941-1948.1999</ArticleId><ArticleId IdType="pmc">PMC104435</ArticleId><ArticleId IdType="pubmed">9971773</ArticleId></ArticleIdList></Reference><Reference><Citation>Lukashev A.N., Vakulenko Y.A. Molecular evolution of types in non-polio enteroviruses. J. Gen. Virol. 2017;98:2968&#x2013;2981. doi: 10.1099/jgv.0.000966.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jgv.0.000966</ArticleId><ArticleId IdType="pubmed">29095688</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan D., Zhang Y., Zhu S., Chen N., Li X., Wang D., Ma X., Zhu H., Tong W., Xu W. Limited and localized outbreak of newly emergent type 2 vaccine-derived poliovirus in Sichuan, China. Clin Vaccine Immunol. 2014;21:1012&#x2013;1018. doi: 10.1128/CVI.00196-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CVI.00196-14</ArticleId><ArticleId IdType="pmc">PMC4097442</ArticleId><ArticleId IdType="pubmed">24850620</ArticleId></ArticleIdList></Reference><Reference><Citation>Nix W.A., Khetsuriani N., Pe&#xf1;aranda S., Maher K., Venczel L., Cselk&#xf3; Z., Freire M.C., Cisterna D., Lema C.L., Rosales P., et al. Diversity of picornaviruses in rural Bolivia. J. Gen. Virol. 2013;94:2017&#x2013;2028. doi: 10.1099/vir.0.053827-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.053827-0</ArticleId><ArticleId IdType="pmc">PMC4637931</ArticleId><ArticleId IdType="pubmed">23804569</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanders R., Maher C., Aylward R.B., Bilous J., Schnur A., Sato Y., Omi S., Tangermann R.H. Development and Coordination of the Polio Laboratory Network in the Western Pacific Region of the World Health Organization. J. Infect. Dis. 1997;175:S117&#x2013;S121. doi: 10.1093/infdis/175.Supplement_1.S117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/175.Supplement_1.S117</ArticleId><ArticleId IdType="pubmed">9203703</ArticleId></ArticleIdList></Reference><Reference><Citation>Apostol L.N., Suzuki A., Bautista A., Galang H., Paladin F.J., Fuji N., Lupisan S., Olveda R., Oshitani H. Detection of non-polio enteroviruses from 17 years of virological surveillance of acute flaccid paralysis in the Philippines. J. Med. Virol. 2012;84:624&#x2013;631. doi: 10.1002/jmv.23242.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.23242</ArticleId><ArticleId IdType="pmc">PMC3500505</ArticleId><ArticleId IdType="pubmed">22337302</ArticleId></ArticleIdList></Reference><Reference><Citation>Bessaud M., Pillet S., Ibrahim W., Joffret M.-L., Pozzetto B., Delpeyroux F., Gouandjika-Vasilache I. Molecular Characterization of Human Enteroviruses in the Central African Republic: Uncovering Wide Diversity and Identification of a New Human Enterovirus A71 Genogroup. J. Clin. Microbiol. 2012;50:1650&#x2013;1658. doi: 10.1128/JCM.06657-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.06657-11</ArticleId><ArticleId IdType="pmc">PMC3347117</ArticleId><ArticleId IdType="pubmed">22337981</ArticleId></ArticleIdList></Reference><Reference><Citation>Benschop K.S.M., Rahamat-Langendoen J.C., Van Der Avoort H.G.A.M., Claas E.C.J., Pas S.D., Schuurman R., Verweij J.J., Wolthers K.C., Niesters H.G.M., Koopmans M.P.G., et al. VIRO-TypeNed, systematic molecular surveillance of enteroviruses in the Netherlands between 2010 and 2014. Eurosurveillance. 2016;21 doi: 10.2807/1560-7917.ES.2016.21.39.30352.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2016.21.39.30352</ArticleId><ArticleId IdType="pmc">PMC5069426</ArticleId><ArticleId IdType="pubmed">27719752</ArticleId></ArticleIdList></Reference><Reference><Citation>Opanda S.M., Wamunyokoli F., Khamadi S., Coldren R., Bulimo W.D. Genotyping of enteroviruses isolated in Kenya from pediatric patients using partial VP1 region. Springerplus. 2016;5:1&#x2013;12. doi: 10.1186/s40064-016-1834-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40064-016-1834-0</ArticleId><ArticleId IdType="pmc">PMC4766141</ArticleId><ArticleId IdType="pubmed">27026855</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-Garcia M.D., Kebe O., Fall A.D., Ndiaye K. Identification and molecular characterization of non-polio enteroviruses from children with acute flaccid paralysis in West Africa, 2013&#x2013;2014. Sci. Rep. 2017;7:1&#x2013;11. doi: 10.1038/s41598-017-03835-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-03835-1</ArticleId><ArticleId IdType="pmc">PMC5476622</ArticleId><ArticleId IdType="pubmed">28630462</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes C.W., Koo S.S., Osman H., Wilson S., Xerry J., Gallimore C.I., Allen D.J., Tang J.W. Predominance of enterovirus B and echovirus 30 as cause of viral meningitis in a UK population. J. Clin. Virol. 2016;81:90&#x2013;93. doi: 10.1016/j.jcv.2016.06.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2016.06.007</ArticleId><ArticleId IdType="pubmed">27367546</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerra J.A., Waters A., Kelly A., Morley U., O&#x2019;Reilly P., O&#x2019;Kelly E. Seroepidemiological and phylogenetic characterization of neurotropic enteroviruses in Ireland, 2005&#x2013;2014. J. Med. Virol. 2017;89:1550&#x2013;1558. doi: 10.1002/jmv.24765.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.24765</ArticleId><ArticleId IdType="pubmed">28071799</ArticleId></ArticleIdList></Reference><Reference><Citation>Papa A., Skoura L., Dumaidi K., Spiliopoulou A., Antoniadis A., Frantzidou F. Molecular epidemiology of Echovirus 6 in Greece. Eur. J. Clin. Microbiol. Infect. Dis. 2009;28:683&#x2013;687. doi: 10.1007/s10096-008-0685-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10096-008-0685-1</ArticleId><ArticleId IdType="pubmed">19130106</ArticleId></ArticleIdList></Reference><Reference><Citation>Bailly J.-L., Mirand A., Henquell C., Archimbaud C., Chambon M., Regagnon C., Charbonn&#xe9; F., Peigue-Lafeuille H. Repeated genomic transfers from echovirus 30 to echovirus 6 lineages indicate co-divergence between co-circulating populations of the two human enterovirus serotypes. Infect. Genet. Evol. 2011;11:276&#x2013;289. doi: 10.1016/j.meegid.2010.06.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.meegid.2010.06.019</ArticleId><ArticleId IdType="pubmed">20615482</ArticleId></ArticleIdList></Reference><Reference><Citation>Smura T., Kakkola L., Blomqvist S., Klemola P., Parsons A., Kallio-Kokko H., Savolainen-Kopra C., Kainov D.E., Roivainen M. Molecular evolution and epidemiology of echovirus 6 in Finland. Infect. Genet. Evol. 2013;16:234&#x2013;247. doi: 10.1016/j.meegid.2013.02.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.meegid.2013.02.011</ArticleId><ArticleId IdType="pubmed">23462388</ArticleId></ArticleIdList></Reference><Reference><Citation>Tao Z., Song Y., Wang H., Zhang Y., Yoshida H., Ji S., Xu A., Song L., Liu Y., Cui N., et al. Intercity Spread of Echovirus 6 in Shandong Province, China: Application of Environmental Surveillance in Tracing Circulating Enteroviruses. Appl. Environ. Microbiol. 2012;78:6946&#x2013;6953. doi: 10.1128/AEM.01861-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AEM.01861-12</ArticleId><ArticleId IdType="pmc">PMC3457494</ArticleId><ArticleId IdType="pubmed">22843520</ArticleId></ArticleIdList></Reference><Reference><Citation>Benschop K.S.M., Geeraedts F., Beuvink B., Spit S.A., Fanoy E.B., Claas E.C.J., Pas S.D., Schuurman R., Verweij J.J., Bruisten S.M., et al. Increase in ECHOvirus 6 infections associated with neurological symptoms in the Netherlands, June to August 2016. Eurosurveillance. 2016;21:21. doi: 10.2807/1560-7917.ES.2016.21.39.30351.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2016.21.39.30351</ArticleId><ArticleId IdType="pmc">PMC5069425</ArticleId><ArticleId IdType="pubmed">27719751</ArticleId></ArticleIdList></Reference><Reference><Citation>Saeed M., Zaidi S.Z., Naeem A., Masroor M., Sharif S., Shaukat S., Angez M., Khan A. Epidemiology and clinical findings associated with enteroviral acute flaccid paralysis in Pakistan. BMC Infect. Dis. 2007;7:6. doi: 10.1186/1471-2334-7-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2334-7-6</ArticleId><ArticleId IdType="pmc">PMC1804272</ArticleId><ArticleId IdType="pubmed">17300736</ArticleId></ArticleIdList></Reference><Reference><Citation>Tao Z., Wang H., Liu Y., Li Y., Jiang P., Liu G., Lin X., Li M., Wang S., Ji F., et al. Non-Polio Enteroviruses from Acute Flaccid Paralysis Surveillance in Shandong Province, China, 1988&#x2013;2013. Sci. Rep. 2014;4:6167. doi: 10.1038/srep06167.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep06167</ArticleId><ArticleId IdType="pmc">PMC4141246</ArticleId><ArticleId IdType="pubmed">25145609</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xd6;sterback R., Kalliokoski T., La&#xa8;hdesma&#xa8;ki T., Peltola V., Ruuskanen O., Waris M. Echovirus 30 meningitis epidemic followed by an outbreak-specific RT-qPCR. J. Clin.Virol. 2015;69:7&#x2013;11. doi: 10.1016/j.jcv.2015.05.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2015.05.012</ArticleId><ArticleId IdType="pubmed">26209368</ArticleId></ArticleIdList></Reference><Reference><Citation>Yarmolskaya M.S., Shumilina E.Y., Ivanova O.E., Drexler J.F., Lukashev A.N. Molecular epidemiology of echoviruses 11 and 30 in Russia: Different properties of genotypes within an enterovirus serotype. Infect. Genet. Evol. 2015;30:244&#x2013;248. doi: 10.1016/j.meegid.2014.12.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.meegid.2014.12.033</ArticleId><ArticleId IdType="pubmed">25562123</ArticleId></ArticleIdList></Reference><Reference><Citation>Richter J., Koptides D., Tryfonos C., Christodoulou C. Molecular typing of enteroviruses associated with viral meningitis in Cyprus, 2000&#x2013;2002. J. Med. Microbiol. 2006;55:1035&#x2013;1041. doi: 10.1099/jmm.0.46447-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jmm.0.46447-0</ArticleId><ArticleId IdType="pubmed">16849723</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H.-G., Lao Q. The pulmonary complications associated with EV71-infected hand&#x2013;foot&#x2013;mouth disease. Radiol. Infect. Dis. 2017;4:137&#x2013;142. doi: 10.1016/j.jrid.2017.01.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jrid.2017.01.001</ArticleId></ArticleIdList></Reference><Reference><Citation>Mbaeyi C., Wadood Z.M., Moran T., Ather F., Stehling-Ariza T., Nikulin J., Al Safadi M., Iber J., Zomahoun L., Abourshaid N., et al. Strategic Response to an Outbreak of Circulating Vaccine-Derived Poliovirus Type 2&#x2014;Syria, 2017-2018. Morb. Mortal. Wkly. Rep. 2018;67:690&#x2013;694. doi: 10.15585/mmwr.mm6724a5.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6724a5</ArticleId><ArticleId IdType="pmc">PMC6013082</ArticleId><ArticleId IdType="pubmed">29927908</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunization Systems Management Group of the Global Polio Eradication Initiative Introduction of Inactivated Poliovirus Vaccine and Switch from Trivalent to Bivalent Oral Poliovirus Vaccine&#x2014;Worldwide, 2013&#x2013;2016. MMWR Morb. Mortal. Wkly. Rep. 2015;64:699&#x2013;702.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4584682</ArticleId><ArticleId IdType="pubmed">26135591</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Y., Wang X., Zhou X., Lv P., Wang H., Song J., Song C., Sun Z. Poliovirus Detection and Genetic Characteristic from Sewage in Heilongjiang Province from 2013 to 2016. Jpn. J. Infect. Dis. 2018;71:442&#x2013;447. doi: 10.7883/yoken.JJID.2017.338.</Citation><ArticleIdList><ArticleId IdType="doi">10.7883/yoken.JJID.2017.338</ArticleId><ArticleId IdType="pubmed">30068885</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Zhu S.L., Zhao R. Study of VP1 region gene code of Sabin-Like strain in acute flaccid paralysis (AFP) clinical case of China. Chin. J. Virol. 2004;20:28&#x2013;33.</Citation></Reference><Reference><Citation>Nomoto A., Omata T., Toyoda H., Kuge S., Horie H., Kataoka Y., Genba Y., Nakano Y., Imura N. Complete nucleotide sequence of the attenuated poliovirus Sabin 1 strain genome. Proc. Natl. Acad. Sci. USA. 1982;79:5793&#x2013;5797. doi: 10.1073/pnas.79.19.5793.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.79.19.5793</ArticleId><ArticleId IdType="pmc">PMC346996</ArticleId><ArticleId IdType="pubmed">6310545</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren R.B., Moss E.G., Racaniello V.R. Identification of two determinants that attenuate vaccine-related type II poliovirus. J. Virol. 1991;65:1377&#x2013;1382. doi: 10.1128/JVI.65.3.1377-1382.1991.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.65.3.1377-1382.1991</ArticleId><ArticleId IdType="pmc">PMC239915</ArticleId><ArticleId IdType="pubmed">1847458</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>